Lecap Asset Management Ltd. Makes New Investment in Azenta, Inc. (NASDAQ:AZTA)

Lecap Asset Management Ltd. acquired a new position in Azenta, Inc. (NASDAQ:AZTA - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 19,309 shares of the company's stock, valued at approximately $669,000.

Several other institutional investors have also added to or reduced their stakes in the company. Principal Financial Group Inc. boosted its stake in shares of Azenta by 94.4% during the fourth quarter. Principal Financial Group Inc. now owns 221,083 shares of the company's stock valued at $11,054,000 after purchasing an additional 107,339 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in Azenta during the 4th quarter valued at approximately $1,080,000. Illinois Municipal Retirement Fund acquired a new position in shares of Azenta in the 4th quarter valued at $1,308,000. Oregon Public Employees Retirement Fund raised its position in Azenta by 7.0% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company's stock worth $535,000 after acquiring an additional 702 shares during the period. Finally, Proficio Capital Partners LLC acquired a new position in Azenta during the fourth quarter worth $910,000. Institutional investors own 99.08% of the company's stock.

Azenta Price Performance

Shares of AZTA traded down $0.18 during mid-day trading on Friday, reaching $30.59. The stock had a trading volume of 7,281,018 shares, compared to its average volume of 728,965. Azenta, Inc. has a 52-week low of $23.91 and a 52-week high of $63.58. The business's fifty day moving average is $27.86 and its 200 day moving average is $38.34. The firm has a market cap of $1.40 billion, a price-to-earnings ratio of -22.01 and a beta of 1.62.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. Azenta's revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.06 EPS. As a group, sell-side analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analysts Set New Price Targets

AZTA has been the subject of a number of recent research reports. TD Cowen upgraded shares of Azenta to a "hold" rating in a research report on Thursday, February 27th. Needham & Company LLC dropped their price objective on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.